Piermont Valley Acquisition Corp. (PVAC) has filed a definitive proxy statement regarding an extraordinary general meeting set for December 9, 2026. This meeting will allow shareholders to vote on a proposed merger with Tigerless Health, Inc. This merger is significant as it highlights the ongoing activity in the blank check company sector, where firms are seeking to capitalize on emerging market opportunities.

The merger, which has already received board approval, involves a series of transactions that will lead to the combination of PVAC and Tigerless Health. Upon completion, Tigerless Health will merge with a subsidiary of PVAC, and PVAC will subsequently merge with another subsidiary, becoming a wholly-owned entity under the new company, Tigerless AI Holdings Inc.

According to the filing, shareholders will have the opportunity to vote on several proposals during the meeting, including the business combination agreement and changes to the organizational documents of the new entity. The merger is expected to result in the issuance of shares of Class A common stock and warrants of the new company, which will be listed on the Nasdaq Stock Market.

PVAC is a blank check company incorporated in the Cayman Islands, primarily focusing on acquiring businesses in the real estate and construction sectors. The company trades on the OTC markets under the tickers CMCAF, CMCUF, and CMCWF. This merger is part of a broader trend in the industry, as more SPACs seek to finalize acquisitions to enhance their market positions.

The filing indicates that shareholders will be able to participate in the virtual meeting and submit questions via a live webcast. It is crucial for shareholders to submit their proxy votes promptly to ensure their interests are represented during the vote.

Following the completion of the merger, the new entity is expected to have a dual common stock structure, with Class A common stock generally having no voting rights and Class B common stock providing one vote per share. The merger could significantly alter the competitive landscape in the health tech sector, particularly as it relates to SPACs.

The filing does not specify what happens next after the shareholder meeting, but the outcomes of the vote will be pivotal for both PVAC and Tigerless Health as they move forward in the merger process.